Sudeep Pharma Limited
964.70
INR
+2.70
(+0.28%)
ISIN
INE0QPI01025
Return %
Stock
S&P 500
1Y
- -
14.39
3Y
- -
81.42
5Y
- -
68.62
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Sujit Jaysukh Bhayani
- Full Time Employees
- 651
- Sector
- Health technology
- Industry
- Pharmaceuticals: other
- Address
- Sears Towers - 2 Vadodara GU India 390021
- IPO Date
- Nov 28, 2025
- Website
- sudeeppharma.com
- Similar Companies
- Business
- Sudeep Pharma Ltd. engages in the manufacturing of excipients and specialty ingredients for pharmaceutical, food, and nutrition industries, with a global footprint through its subsidiaries and manufacturing facilities. Headquartered in Vadodara, India, the company operates across multiple regions including the United States, Europe, the Netherlands, Ireland, and India, serving a global customer base with a focus on mineral-based excipients and iron-based actives; it develops value-added formulations and customized ingredient solutions to support drug dosage forms, dietary supplements, infant nutrition, dairy, bakery, beverages, confectionery, and other nutrition and food applications. The company emphasizes calcium-based excipients and related mineral additives as core products, along with iron excipients and actives, to support pharmaceutical and nutrition markets worldwide. Founding year and corporate structure - Founded in 1989 (as per corporate history), with headquarters in Vadodara, Gujarat, India. - Maintains international subsidiaries and manufacturing facilities, including in the United States (warehousing and distribution), the Netherlands (subsidiary presence and operations), and Ireland (subsidiary operations), enabling global reach and localized support. Main products and services - Core product categories: mineral-based excipients; iron excipients and actives; other calcium, magnesium, zinc, potassium, and sodium-based excipients; specialty ingredients for pharmaceuticals and nutrition. - Specific product types: ferric and ferrous iron salts and complexes (e.g., ferric pyrophosphate, ferric orthophosphate, ferrous fumarate, ferrous sulfate, ferrous gluconate, iron hydoxide polymaltose, electrolytic iron, reduced iron), calcium-based excipients and additives, and related mineral-based functional ingredients. - Service offerings: custom formulation development; ingredient sourcing and supply chain management; regulatory and quality assurance support; contract manufacturing for excipients and specialty ingredients; global distribution and warehousing; technical support and application development for pharmaceuticals, dietary supplements, infant nutrition, and dairy/beverage applications. - Packaging and logistics services: integrated supply chain support across multiple regions, enabling timely delivery to customers in 100+ countries as cited in market analyses, with emphasis on quality, traceability, and regulatory compliance. Latest major company changes - Strategic international expansion, including incorporation and operations of subsidiaries in the United States, the Netherlands, and Ireland to broaden global market access and logistics efficiency. - Ongoing capacity expansion projects, including the development of new manufacturing facilities in India to increase annual production capacity for excipients and specialty ingredients; announced expansions are aimed at meeting rising demand in pharmaceuticals and nutrition sectors and positioning the company for multi-year growth. - Product portfolio enhancements and formulations: introduction of novel formulations and premium product lines (e.g., Novelcap, Lipoboost) aimed at improving product performance and applications in food, pharmaceuticals, and dietary supplements. - Corporate reorganizations and regional focus shifts intended to optimize manufacturing footprint, streamline operations, and strengthen customer-facing capabilities across major markets. Industry context and markets - Industry verticals: pharmaceuticals (excipients and active ingredients), dietary supplements, infant nutrition, dairy and beverage ingredients, bakery and confectionery ingredients, and staple food applications. - Target customers: pharmaceutical manufacturers, contract manufacturers, dietary supplement producers, food and beverage companies, and distributors requiring mineral-based excipients and specialty ingredients. - Geographic footprint: global operations with manufacturing and warehousing in India and the US; subsidiaries in Europe (Netherlands, Ireland) to support European and international customers; exports to 100+ countries. - Corporate relationships: operates as a standalone entity with international subsidiaries; potential parent/subsidiary arrangements reinforce global supply chain integration. Notes - The description reflects publicly available information on Sudeep Pharma Ltd. and summarizes core activities, products, and notable strategic developments, emphasizing current products and recent changes in structure and capacity to illustrate the company’s evolving global footprint and offerings.